文献速递消化道肿瘤放疗

食管癌微观肿瘤播散超出内镜确定边界的病理验证

Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.
PubMed 文献 · Radiat Oncol · 2019-12-04

结果显示无宏观肿瘤超出EDTB,残留肿瘤组仅20%和21%的颅尾侧EDTB有MS,最大9mm和16mm,支持以基准标记确定GTV时CTV外扩可限于1-1.5cm。

要点

  • 基准标记置于EDTB可准确代表宏观肿瘤边界。
  • 残留肿瘤组颅尾侧EDTB仅20%和21%有微观播散。
  • 微观播散最大9mm和16mm,支持CTV外扩1-1.5cm。

核心结论

  • 基准标记置于EDTB可作为宏观肿瘤边界的替代,支持将食管壁方向CTV外扩限制在1-1.5cm。

主要发现

  • 32例患者共60个EDTB被分析,50%患者为残留肿瘤组(Mandard≥3)。
  • 无患者出现宏观肿瘤超出EDTB。
  • 残留肿瘤组颅侧和尾侧EDTB分别仅20%和21%有MS,最大分别为9mm和16mm。
  • MS超出EDTB与初始肿瘤长度显著相关(p=0.028)。

关键数值与推荐

  • 以基准标记确定GTV时,食管壁方向CTV外扩可限于1-1.5cm。

临床怎么用

  • 使用基准标记确定食管癌GTV时,可考虑将CTV外扩从传统3-5cm缩小至1-1.5cm。

局限性

  • 样本量较小(32例分析),需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The microscopic tumor spread (MS) beyond the macroscopic tumor borders of esophageal tumors is crucial for determining the clinical target volume (CTV) in radiotherapy. The question arises whether current voluminous CTV margins of 3-5 cm around the macroscopic gross tumor volume (GTV) to account for MS are still accurate when fiducial markers are used for GTV determination. We aimed to pathologically validate the use of fiducial markers placed on the (echo)endoscopically determined tumor border (EDTB) as a surrogate for macroscopic tumor borders and to analyse the MS beyond EDTBs. METHODS: Thirty-three consecutive esophageal cancer patients treated with neo-adjuvant chemoradiotherapy after (echo)endoscopic fiducial marker implantation at cranial and caudal EDTB were included in this study. Fiducial marker positions were detected in the surgical specimens under CT guidance and demarcated with beads, and subsequently analysed for macroscopic tumor spread and MS beyond the demarcations. A logistic regression analysis was performed to determine predicting factors for MS beyond EDTB. RESULTS: A total of 60 EDTBs were examined in 32 patients. In 50% of patients no or only partial regression of tumor in response to therapy (≥Mandard 3) or higher was seen (i.e., residual tumor group) and included for MS analysis. None had macroscopic tumor spread beyond EDTBs. In the residual tumor group, only 20 and 21% of the cranial and caudal EDTBs were crossed with a maximum of 9 mm and 16 mm MS, respectively. This MS was corrected for each individual determined contraction rate (mean: 93%). Presence of MS beyond EDTB was significantly associated with initial tumor length (p = 0.028). CONCLUSION: Our results validate the use of fiducial markers on EDTB as a surrogate for macroscopic tumor and indicate that CTV margins around the GTV to compensate for MS along the esophageal wall can be limited to 1-1.5 cm, when the GTV is determined with fiducial markers.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Machiels M, van Montfoort ML, Thuijs NB, et al. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer. Radiat Oncol. 2019. PMID: 31801574. doi:10.1186/s13014-019-1419-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。